Management of chronic respiratory diseases using digital health tools
Integrated Management of Chronic Respiratory Diseases - eMEUSE-SANTE
This study is testing whether using digital health tools can help people with obstructive sleep apnea and COPD manage their conditions better and improve their overall health.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 400 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Sponsor | University Hospital, Grenoble Academic / other |
| Locations | 2 sites (Grenoble and 1 other locations) |
| Trial ID | NCT04963192 on ClinicalTrials.gov |
What this trial studies
This study focuses on the integrated management of chronic respiratory diseases, specifically obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD), through the use of digital health technologies. It aims to utilize connected devices to monitor patients' health metrics and provide personalized therapeutic education, enhancing the management of these conditions. The approach includes telemonitoring of treatment compliance and the collection of big data to assess the effectiveness of interventions like CPAP and non-invasive ventilation. By coordinating care and utilizing e-health solutions, the study seeks to improve patient outcomes and reduce healthcare costs associated with these diseases.
Who should consider this trial
Good fit: Ideal candidates include patients newly diagnosed with obstructive sleep apnea requiring CPAP treatment or those with COPD needing non-invasive ventilation or oxygen therapy.
Not a fit: Patients who are pregnant, unable to provide consent, or currently participating in another clinical study may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management and outcomes for patients with chronic respiratory diseases.
How similar studies have performed: Other studies have shown promise in using digital health tools for managing chronic diseases, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient with a chronic respiratory pathology such as: * Newly diagnosed OSA with indication for CPAP treatment * And/or COPD with or without indication for NIV/oxygen therapy * Have a smartphone (with Android or iOS) allowing the installation of applications for connected objects * Be able to use a mobile application on a personal smartphone * Person agreeing to the telemonitoring of CPAP or NIV/oxygen therapy compliance data by the healthcare provider * Patient who has provided consent to participate in the study * Person affiliated to the social security Exclusion Criteria: * Pregnant or breastfeeding woman * Patient unable to give consent to participate in the study * Patient under guardianship or curatorship * Patient not affiliated to the social security system * Patient deprived of liberty or hospitalized * Patient protected by law * Patient under administrative or judicial control * Patient currently participating in another clinical research study that may have an impact on the study, this impact is left to the discretion of the investigator
Where this trial is running
Grenoble and 1 other locations
- Grenoble Alpes University Hospital — Grenoble, France (Enrolling_by_invitation)
- Verdun Hospital — Verdun, France (Recruiting)
Study contacts
- Principal investigator: Jean-Louis PEPIN, MD, PhD — Grenoble Alpes University Hospital
- Study coordinator: Marie JOYEUX-FAURE, PharmD, PhD
- Email: mjoyeuxfaure@chu-grenoble.fr
- Phone: 334 767 692 65
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.